Ontology highlight
ABSTRACT:
SUBMITTER: Jalkh G
PROVIDER: S-EPMC7823546 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature
Vaccines 20201226 1
In the past decade, the therapeutic arsenal for multiple sclerosis has expanded greatly. Newer more potent disease modifying therapies (DMTs) with varying mechanisms of actions are increasingly used early in the disease course. These newer DMTs include oral therapies (teriflunomide, dimethyl fumarate, fingolimod, siponimod, ozanimod, and cladribine) and infusion therapies (natalizumab, alemtuzumab, and ocrelizumab), and are associated with better control of disease activity and long-term outcome ...[more]